This inventor holds 5 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignee: Farmak, A.s.. Active years: 2011-2016.
Company Filing History:
Years Active: 2011-2016
Title: Martin Grepl: Innovator in Pharmaceutical Chemistry
Introduction
Martin Grepl is a notable inventor based in Hlusovice, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work primarily focuses on the development of innovative compounds that have potential applications in medical imaging and therapeutic treatments.
Latest Patents
One of Martin Grepl's latest inventions involves a compound known as 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine. This compound acts as a selective A2A adenosine receptor agonist, which is particularly useful in myocardial imaging. Additionally, he has developed a new polymorph of this compound, designated as polymorph E. This polymorph is characterized by an X-ray diffraction pattern that reveals specific reflections at various angles, as well as distinct thermal and infrared properties. The method for preparing this polymorph involves recrystallization from other forms of the compound using a polar aprotic solvent, followed by a series of heating and cooling steps.
Another significant patent pertains to the preparation of N-(1-benzo[b]thien-2-ylethyl)-N-hydroxyurea. This method utilizes a reaction between 1-(benzo[b]thien-2-yl)-ethanol and hydroxyurea in various organic solvents, catalyzed by strongly acidic cation exchangers or hydrogen sulphates.
Career Highlights
Throughout his career, Martin Grepl has worked with several reputable companies, including Farmak, A.S. and Scale Up Laboratory, S.R.O. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects in the pharmaceutical sector.
Collaborations
Martin has collaborated with notable colleagues such as Pavel Hradil and Lubomir Kvapil. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Martin Grepl is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of innovative compounds with significant medical applications. His contributions continue to impact the field positively, showcasing the importance of research and innovation in healthcare.